Rajangam Kanya
- SEC CIK
- 0001816676
No open-market purchases or sales filed in the past year.
Current role at each company
- SNTI Senti Biosciences Holdings, Inc.Pres. & Chief Med. & Dev. Off.as of Mar 11, 2026
- TSBX Turnstone Biologics Corp.Directoras of Jul 2, 2024
- NKTX Nkarta, Inc.Chief Medical Officeras of Jan 19, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Rajangam Kanya as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
SNTI Senti Biosciences Holdings, Inc.
Pres. & Chief Med. & Dev. Off.1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 6, 2025 (view filing) | Feb 4-6 | 2 days | Rajangam KanyaPres. & Chief Med. & Dev. Off. | SSale | −1.48K | $4.11 | −$6.07K | −14.6%8.62K after | 2 lots |
NKTX Nkarta, Inc.
Chief Medical Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 9, 2021 (view filing)5:17 PM ET | Aug 5 | 4 days | Rajangam KanyaChief Medical Officer | SSale | −10.0K | $37.28 | −$372.8K | −100.0%0 after |